Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
Symbol ANGPTL3 contributors: mct/npt/pgu - updated : 06-06-2016
HGNC name angiopoietin-like 3
HGNC id 491
TYPE functioning gene
SPECIAL FEATURE gene in gene
  • located in an intron of DOCK7
  • STRUCTURE 8.82 kb     7 Exon(s)
    Genomic sequence alignment details
    10 Kb 5' upstream gene genomic sequence study
    MAPPING cloned Y linked N status provisional
    Map pter - D1S203 - D1S822 - D1S2788 - D1S209 - D1S246 - ANGPTL3 - D1S2835 - cen
    Authors Gene Map (99)
    Physical map
    TACSTD2 1p32-p31 tumor-associated calcium signal transducer 2 AK2B 1p32.1 adenylate kinase 2 pseudogene KIAA1915 1p32.1 KIAA1915 protein JUN 1p32-p31 v-jun sarcoma virus 17 oncogene homolog (avian) LOC391044 1 similar to prohibitin FLJ10986 1p32.1 hypothetical protein FLJ10986 HOOK1 1p32.1 hook homolog 1 (Drosophila) CYP2J2 1p31.3-p31.2 cytochrome P450, family 2, subfamily J, polypeptide 2 MGC34837 1p32.1 hypothetical protein MGC34837 NFIA 1p31.3-p31.2 nuclear factor I/A BBP 1p32.1 beta-amyloid binding protein precursor INADL 1p32.1-p31.3 beta-amyloid binding protein precursor FLJ10884 1p32.1 hypothetical protein FLJ10884 LOC388637 1 similar to LOC163782 protein USP1 1p32.1-p31.3 ubiquitin specific protease 1 ANGPTL3 1p31 angiopoietin-like 3 AUTL1 1p31.3 AUT-like 1, cysteine endopeptidase (S. cerevisiae) LOC199897 1p32.1 hypothetical LOC199897 LOC388638 1 LOC388638 FOXD3 1p32-p31 forkhead box D3 ALG6 1p31.3 forkhead box D3 ITGB3BP 1p31.3 integrin beta 3 binding protein (beta3-endonexin) KIAA1799 1p31.3 KIAA1799 protein PGM1 1p22.3 phosphoglucomutase 1 ROR1 1p32-p31 receptor tyrosine kinase-like orphan receptor 1 MGC35130 1p31.3 hypothetical protein MGC35130 KIAA1573 1p31.3 KIAA1573 protein KIAA1579 1p31.3 hypothetical protein FLJ10770 JAK1 1p31.3 Janus kinase 1 (a protein tyrosine kinase) LOC391045 1 similar to Solute carrier family 2, facilitated glucose transporter, member 3 (Glucose transporter type 3, brain) MRPS21P1 1p31.3 mitochondrial ribosomal protein S21 pseudogene AK3 1p31 adenylate kinase 3 DNAJC6 1pter-q31.3 DnaJ (Hsp40) homolog, subfamily C, member 6 LEPR 1p31 leptin receptor PDE4B 1p31 phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila) DKFZp761D221 1p31.3 hypothetical protein DKFZp761D221
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    - - 4500 - - - 1999 10644446
    - - 3000 - - - 1999 10644446
    - - 2800 - - - 1999 10644446
    - - 1700 - - liver and kidney 1999 10644446
    7 - 2126 53 460 - 2009 19028676
       expressed in (based on citations)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Digestiveliver   moderately
    Urinarykidneynephronrenal capsuleglomeruluslowly
    SystemCellPubmedSpeciesStageRna symbol
    cell lineage
    cell lines
    at STAGE
  • a 19 AAs N terminal signal sequence, with a trimeric coiled-coil (CLD)
  • a short linker
  • a globular fibrinogen homology domain (FHD) with four cysteine residues implicated in intramolecular disulfide bonds
  • two potential N-glycosylation sites
  • a C-terminal fibrinogen (FBN)-like domain mediating binding to the TIE2 receptor and regulating blood vessel formation
  • secondary structure
  • an extended helical domain predicted to form dimeric or trimeric coiled-coils
  • conjugated GlycoP
    isoforms Precursor a mature protein of 441 aa for 51.5 kda
    interspecies homolog to murine Angptl3
    homolog to rattus Angptl3
    homolog to zebrafish angptl3
    intraspecies paralog to ANGPTL8
  • angiopoietin-like family
  • CATEGORY adhesion , regulatory , signaling growth factor
    basic FUNCTION
  • regulating positively lipid metabolism (activating the lipolysis to stimulate the release of free fatty acid and glycerol from adipocytes)
  • playing a role in the positive regulation of angiogenesis
  • acting as an enzyme inhibitor (inhibiting the activity of lipoprotein lipase)
  • acting as an inhibitor of endothelial lipase and may be involved in the regulation of plasma HDL cholesterol and HDL-phospholipid levels
  • ANGPTL3, 4, and ANGPTL6/angiopoietin-related growth factor also appear to directly regulate lipid, glucose, and energy metabolism independently of angiogenic effects
  • play important roles in modulating lipoprotein metabolism in the body
  • ANGPTL3, ANGPTL4, and ANGPTL5, but not ANGPTL6, play nonredundant roles in triglyceride metabolism
  • involved in cell-matrix adhesion
  • secreted protein that regulate triglyceride (TG) metabolism in part by inhibiting lipoprotein lipase (LPL)
  • ANGPTL3, ANGPTL4, and possibly ANGPTL5 are regulators of lipoprotein metabolism
  • enhances LPL cleavage in the presence of either heparan sulfate proteoglycans or glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1)
  • ANGPTL3 inhibits lipoprotein lipase activity through enhancing its cleavage by PCSK5
  • capable of regulating the motility and permeability of podocytes and the mechanism of its regulation could be associated with the altered expression of nephrin
  • could be involved in proteinuria development and in podocyte injury
  • plays an important role in regulating the expression of nephrin in pathologic conditions
  • ANGPTL3, -4 and ANGPTL6/angiopoietin-related growth factor (AGF) directly regulate lipid, glucose and energy metabolism independent of angiogenic effects
  • act through its coiled-coil domains to enhance survival and replating capacity of human cord blood hematopoietic progenitors
  • possible role of ANGPTL3 at the crossroads of lipoproteins, fatty acids, and glucose metabolism
  • might play a crucial role in podocyte injury
  • inhibits two intravascular lipases, LPL and endothelial lipase, and the low plasma TG and HDL-cholesterol levels in ANGPTL3 deficiency reflect increased activity of these enzymes
  • plays a major role in promoting uptake of circulating very low density lipoprotein-triglycerides (VLDL-TGs) into white adipose tissue (WAT) rather than oxidative tissues (skeletal muscle, heart brown adipose tissue) in the fed state
  • regulates adipose tissue energy homeostasis
  • plays an important role in angiogenesis
  • secretory protein regulating plasma lipid levels via affecting lipoprotein lipase- and endothelial lipase-mediated hydrolysis of triglycerides and phospholipids
  • CELLULAR PROCESS cell migration & motility
  • angiogenesis
  • positive regulation of cell migration
    metabolism lipid/lipoprotein
    signaling signal transduction
  • integrin-mediated signaling pathway
  • lipid catabolism, triacylglycerol metabolism
  • a component
    small molecule
  • ITGB3
  • inhibit LPL activity through distinct mechanisms
  • potent inhibitor of LPL
  • FURIN is the primary convertase of ANGPTL3 and endothelial lipase in hepatocytes
  • ANGPTL8 also called betatrophin is a regulator of lipid metabolism through its interaction with ANGPTL3
  • cell & other
    activated by cleavage
    induced by LXR- or retinoid X receptor-selective agonists
    corresponding disease(s) FHBL2
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --over  
    significantly increased podocyte motility, and dramatically increased the expression of nephrin
    tumoral     --over  
    in esophageal cancer tissues
    constitutional       loss of function
    does not affect the number of APOB-containing lipoproteins secreted by the liver but alters the particles that are made such that they are cleared more rapidly from the circulation via a noncanonical pathway(s)
    constitutional     --over  
    in glomerular podocytes of nephrotic syndrome
    constitutional       loss of function
    results in very low levels of LDL-cholesterol (C), HDL-C and triglyceride (TAG)
    Susceptibility atherosclerosis, coronary artery disease, diabetes mellitus
    Variant & Polymorphism
    Candidate gene
  • association of ANGPTL3 expression with the prognosis of subgroups of patients with esophageal cancer
  • Therapy target
    therapeutic antibodies that neutralize ANGPTL4 and ANGPTL3 may be useful for treatment of some forms of hyperlipidemia
    potential therapeutic target to treat combined hyperlipidemia, a major risk factor for atherosclerotic coronary heart disease
    KK obese mouse